Evidence check: FT3 in the context of longevity

The question about FT3 (free triiodothyronine) in the context of longevity is scientifically intriguing, but the provided context offers no direct evidence. FT3 is the active thyroid hormone regulating metabolism. Some observational studies suggest that low FT3 levels (euthyroid sick syndrome) in older adults are associated with increased mortality, while high levels indicate hyperthyroidism. However, there are no robust randomized controlled trials proving a causal link between FT3 optimization and extended lifespan. Most data are observational and confounded by underlying illness or lifestyle. Consumer DNA tests or metabolism analyses (e.g., from MyBody-X) typically do not measure blood FT3; they focus on genetic predispositions or indirect biomarkers. Measuring FT3 alone without clinical context (TSH, fT4, symptoms) is not meaningful for longevity advice. Moreover, supplementing with thyroid hormones without medical supervision is dangerous. In summary, the evidence is weak and mixed; no general recommendation for FT3 optimization for longevity can be made. Be cautious of marketing claims based on single biomarkers.